Home›Companies›Biotech & Pharma›Starget Pharma

Starget Pharma Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 3, 2026·Suggest an edit

About Starget Pharma

Starget Pharma is a private company based in Shreveport, Louisiana, incorporated in 2025 in Delaware. It has reported $16,373,737 raised in one offering on Form D since February 2026. Its chief executive is Sigal Kalmanson Cusnir.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 20, 2026Feb 3, 2026$16,373,737of $22.1M target29$564KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Starget Pharma's Form D filed Feb 3, 2026.

Sources

  1. SECStarget Pharma Inc. filing history